Abstract
Identification and susceptibility studies were performed on 301 blood and urine Streptococcus faecalis and Streptococcus faecium isolates. Strep Trio-Tubes S4, S5, and S3 (Carr-Scarborough Microbiologicals, Inc.) were compared with conventional methods for accuracy and rapidity. Of 282 isolates identified as S. faecalis, 98% were identified by species in 4 h with Trio-Tubes; the same percentage of isolates analyzed by conventional methods were identified in 24 h. All 14 S. faecium isolates (approximately 5% of the total number of isolates) were identified by Trio-Tubes in 24 h. In vitro MIC susceptibility testing of the isolates was performed by the Dynatech 2000 microdilution technique (Dynatech Laboratories, Inc.). Several newly developed antimicrobial agents, including imipenem (a carbapenem) and some of the quinolone drugs, i.e., CI-934, ciprofloxacin, A-56619, A-56620, amifloxacin, norfloxacin, and enoxacin, were tested, as were ampicillin, erythromycin, and vancomycin. Both ampicillin and vancomycin showed good activity against S. faecalis, with MICs for 90% of isolates tested (MIC90S) of 1 and 2 micrograms/ml, respectively; with S. faecium, ampicillin exhibited an MIC90 of 16 micrograms/ml and vancomycin exhibited an MIC90 of 2 micrograms/ml. Of the newer antimicrobial agents, imipenem and CI-934 exhibited the greatest activity against S. faecalis strains, with MIC90S of 2 and 0.5 micrograms/ml, respectively. MBCs against the isolates were determined with CI-934, with 90% of S. faecalis strains showing MBCs of 1 microgram/ml or less.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Birnbaum J., Kahan F. M., Kropp H., MacDonald J. S. Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin. Am J Med. 1985 Jun 7;78(6A):3–21. doi: 10.1016/0002-9343(85)90097-x. [DOI] [PubMed] [Google Scholar]
- Bosley G. S., Facklam R. R., Grossman D. Rapid identification of enterococci. J Clin Microbiol. 1983 Nov;18(5):1275–1277. doi: 10.1128/jcm.18.5.1275-1277.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cohen M. A., Griffin T. J., Bien P. A., Heifetz C. L., Domagala J. M. In vitro activity of CI-934, a quinolone carboxylic acid active against gram-positive and -negative bacteria. Antimicrob Agents Chemother. 1985 Dec;28(6):766–772. doi: 10.1128/aac.28.6.766. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Coudron P. E., Mayhall C. G., Facklam R. R., Spadora A. C., Lamb V. A., Lybrand M. R., Dalton H. P. Streptococcus faecium outbreak in a neonatal intensive care unit. J Clin Microbiol. 1984 Dec;20(6):1044–1048. doi: 10.1128/jcm.20.6.1044-1048.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eliopoulos G. M., Moellering A. E., Reiszner E., Moellering R. C., Jr In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620. Antimicrob Agents Chemother. 1985 Oct;28(4):514–520. doi: 10.1128/aac.28.4.514. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Esko E., Renkonen O. V. Comparative in vitro activity of norfloxacin and seven other antimicrobial agents against clinical isolates from urinary tract infections. Scand J Infect Dis. 1985;17(1):95–98. doi: 10.3109/00365548509070427. [DOI] [PubMed] [Google Scholar]
- Forsgren A. Comparative in vitro activity of three new quinolone antibiotics against recent clinical isolates. Scand J Infect Dis. 1985;17(1):91–94. doi: 10.3109/00365548509070426. [DOI] [PubMed] [Google Scholar]
- King A., Shannon K., Phillips I. The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin. J Antimicrob Chemother. 1985 May;15(5):551–558. doi: 10.1093/jac/15.5.551. [DOI] [PubMed] [Google Scholar]
- Marier R. L. Role of imipenem/cilastatin in the treatment of soft tissue infections. Am J Med. 1985 Jun 7;78(6A):140–144. doi: 10.1016/0002-9343(85)90117-2. [DOI] [PubMed] [Google Scholar]
- Tofte R. W., Solliday J. A., Crossley K. B. Susceptibilities of enterococci to twelve antibiotics. Antimicrob Agents Chemother. 1984 Apr;25(4):532–533. doi: 10.1128/aac.25.4.532. [DOI] [PMC free article] [PubMed] [Google Scholar]